McLaughlin Erica
Known title: Senior Vice President, CFOCIK: 0001740348
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Cabot Corp to Report Q4 FY2026 Results. Cabot Corporation will release its fourth‑quarter and full‑year 2026 operating results on Friday. The announcement follows a period of steady performance and may influence the stock’s near‑term movement. A recent article highlighted the company’s dividend yield of 2.06% and earnings guidance as key factors for investors. The stock is currently trading near its 52‑week low and close to a support level of $74.80.
Transaction History
| AZTA | ▲ Buy | Grant | 5,663 | $158K | 2/5/2026 | View on chart |
| CBT | ▲ Buy | Grant | 8,283 | $0 | 11/19/2025 | View on chart |
| CBT | ▲ Buy | Grant | 6,943 | $0 | 11/19/2025 | View on chart |
| CBT | ▼ Sell | Tax Withholding | 2,259 | $135K | 11/19/2025 | View on chart |
| CBT | ▼ Sell | Tax Withholding | 2,253 | $138K | 11/11/2025 | View on chart |
| CBT | ▼ Sell | Gift | 1,299 | $0 | 6/12/2025 | View on chart |
| AZTA | ▲ Buy | Grant | 4,040 | $211K | 2/7/2025 | View on chart |
| CBT | ▲ Buy | Grant | 10,090 | $0 | 11/18/2024 | View on chart |
| CBT | ▼ Sell | Tax Withholding | 4,197 | $457K | 11/18/2024 | View on chart |
| CBT | ▼ Sell | Tax Withholding | 2,552 | $287K | 11/12/2024 | View on chart |
| CBT | ▲ Buy | Grant | 3,913 | $0 | 11/8/2024 | View on chart |
| CBT | ▲ Buy | Option Exercise | 11,714 | $588K | 8/27/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 11,714 | $1.2M | 8/27/2024 | View on chart |
| CBT | ▲ Buy | Option Exercise | 4,676 | $234K | 8/27/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 4,676 | $489K | 8/27/2024 | View on chart |
| CBT | ▲ Buy | Option Exercise | 8,069 | $403K | 8/8/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 8,069 | $792K | 8/8/2024 | View on chart |
| CBT | ▲ Buy | Option Exercise | 3,013 | $151K | 8/8/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 3,013 | $295K | 8/8/2024 | View on chart |
| CBT | ▲ Buy | Option Exercise | 12,309 | $618K | 8/7/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 2,675 | $269K | 8/7/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 1,050 | $107K | 8/7/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 848 | $87K | 8/7/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 200 | $21K | 8/7/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 5,686 | $561K | 8/7/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 1,850 | $184K | 8/7/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 26 | $3K | 8/7/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 4,670 | $461K | 8/7/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 2,141 | $213K | 8/7/2024 | View on chart |
| CBT | ▲ Buy | Option Exercise | 10,965 | $548K | 8/7/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 2,328 | $234K | 8/7/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 1,000 | $102K | 8/7/2024 | View on chart |
| CBT | ▼ Sell | Open Market | 800 | $82K | 8/7/2024 | View on chart |
| AZTA | ▲ Buy | Grant | 2,465 | $163K | 2/12/2024 | View on chart |
| CBT | ▲ Buy | Option Exercise | 36,119 | $1.5M | 12/14/2023 | View on chart |
| CBT | ▼ Sell | Open Market | 36,007 | $2.9M | 12/14/2023 | View on chart |
| CBT | ▼ Sell | Open Market | 112 | $9K | 12/14/2023 | View on chart |
| CBT | ▲ Buy | Grant | 7,969 | $0 | 11/20/2023 | View on chart |
| CBT | ▼ Sell | Tax Withholding | 8,261 | $643K | 11/20/2023 | View on chart |
| CBT | ▼ Sell | Tax Withholding | 3,291 | $244K | 11/13/2023 | View on chart |
| CBT | ▲ Buy | Grant | 5,443 | $0 | 11/10/2023 | View on chart |
| AZTA | ▲ Buy | Grant | 3,604 | $0 | 2/13/2023 | View on chart |
| CBT | ▲ Buy | Grant | 13,462 | $0 | 11/21/2022 | View on chart |
| CBT | ▼ Sell | Tax Withholding | 3,136 | $224K | 11/21/2022 | View on chart |
| CBT | ▲ Buy | Grant | 5,078 | $0 | 11/11/2022 | View on chart |
| CBT | ▼ Sell | Tax Withholding | 2,186 | $153K | 11/8/2022 | View on chart |
| CBT | ▲ Buy | Option Exercise | 2,295 | $106K | 5/31/2022 | View on chart |
| CBT | ▲ Buy | Option Exercise | 3,293 | $130K | 5/31/2022 | View on chart |
| CBT | ▲ Buy | Option Exercise | 3,534 | $178K | 5/31/2022 | View on chart |
| CBT | ▼ Sell | Open Market | 3,007 | $229K | 5/31/2022 | View on chart |
| CBT | ▼ Sell | Open Market | 1,780 | $139K | 5/31/2022 | View on chart |
| CBT | ▼ Sell | Open Market | 4,335 | $334K | 5/31/2022 | View on chart |
| AZTA | ▲ Buy | Grant | 1,922 | $0 | 2/11/2022 | View on chart |
| CBT | ▲ Buy | Grant | 11,164 | $0 | 11/22/2021 | View on chart |
| CBT | ▼ Sell | Tax Withholding | 1,059 | $63K | 11/22/2021 | View on chart |
| CBT | ▲ Buy | Grant | 5,277 | $0 | 11/12/2021 | View on chart |
| CBT | ▼ Sell | Tax Withholding | 1,365 | $79K | 11/9/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
AZTA Featured in Volatile Stock List
Azenta Inc. was included in a recent article discussing volatile stocks with promising prospects. The stock is currently trading within its 52-week range, with analysts maintaining an average price target of $37.00. This mention highlights the company's status as a high-beta asset in the current market environment.
AZTA Featured in Volatile Stock List. Azenta Inc. was included in a recent article discussing volatile stocks with promising prospects. The stock is currently trading within its 52-week range, with analysts maintaining an average price target of $37.00. This mention highlights the company's status as a high-beta asset in the current market environment.